Genetics of Parkinson's disease and parkinsonism.Ann Neurol. 2006 Oct; 60(4):389-98.AN
Abstract
Until 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1-PARK12 (OMIM 168600). Recently, these research findings have begun to impact clinical practice, and this impact is likely to increase. The primary purpose of this article is to outline these genetic advances, discuss their importance for current practice in clinical and related settings, and outline briefly how they are influencing research into the causes of and possible future treatments for this prevalent disorder.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, N.I.H., Intramural
Review
Language
eng
PubMed ID
17068789
Citation
Hardy, John, et al. "Genetics of Parkinson's Disease and Parkinsonism." Annals of Neurology, vol. 60, no. 4, 2006, pp. 389-98.
Hardy J, Cai H, Cookson MR, et al. Genetics of Parkinson's disease and parkinsonism. Ann Neurol. 2006;60(4):389-98.
Hardy, J., Cai, H., Cookson, M. R., Gwinn-Hardy, K., & Singleton, A. (2006). Genetics of Parkinson's disease and parkinsonism. Annals of Neurology, 60(4), 389-98.
Hardy J, et al. Genetics of Parkinson's Disease and Parkinsonism. Ann Neurol. 2006;60(4):389-98. PubMed PMID: 17068789.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Genetics of Parkinson's disease and parkinsonism.
AU - Hardy,John,
AU - Cai,Huaiban,
AU - Cookson,Mark R,
AU - Gwinn-Hardy,Katrina,
AU - Singleton,Andrew,
PY - 2006/10/28/pubmed
PY - 2006/12/9/medline
PY - 2006/10/28/entrez
SP - 389
EP - 98
JF - Annals of neurology
JO - Ann Neurol
VL - 60
IS - 4
N2 - Until 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1-PARK12 (OMIM 168600). Recently, these research findings have begun to impact clinical practice, and this impact is likely to increase. The primary purpose of this article is to outline these genetic advances, discuss their importance for current practice in clinical and related settings, and outline briefly how they are influencing research into the causes of and possible future treatments for this prevalent disorder.
SN - 0364-5134
UR - https://www.unboundmedicine.com/medline/citation/17068789/Genetics_of_Parkinson's_disease_and_parkinsonism_
L2 - https://doi.org/10.1002/ana.21022
DB - PRIME
DP - Unbound Medicine
ER -